Taste of M&A Monday; A special kind of lab; Biotech founder wins Nobel; BioMarin layoffs; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Zoom can only go so far. That’s the mindset John Carroll will be bringing to London next week for the first time in several years. If you’re there, consider joining him as he chats with a small crowd of biopharma people — we also have virtual options.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,600+ biopharma pros reading Endpoints daily — and it's free.